A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A Randomized, Double‐Masked, Vehicle‐Controlled Crossover Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
Epistemonikos ID: 8385fc914b65308ca03c165b9eb54d4466a7a9cc
First added on: Dec 20, 2022